USPTO Patents Application 09934948

o

is-.?

u

iw Attorney Docket No.: 6229.200-US PATENT S

ft co

1 1 IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

FILING UNDER 37 C.F.R. 1.53(b)

Box Patent Application
Commissioner for Patents
Washington, DC 20231

Express Mail Label No. EL293691641US
Date of Deposit August 22, 2001

Sir:

This is a request for filing a patent application under 37 C.F.R. 1.53(b) of
Applicant(s): Christian Grondahl et al.

Title: Receptors and Signalling Proteins Capable of Binding Meiotic Acting
Sterols (MAS)

29 pages of specification J_ sheet of Formal Drawings
3 sheets of Declaration and Power of Attorney
18 sheets Sequence Listing

\Cy [x] The filing fee is calculated as follows:

^ Basic Fee: $ 710.00

Q Total Claims: 47 - 20 = 27 x 18 = $ 486.00

I*

Independent Claims: 18 - 3 = 15 x 80 = $1,200.00

Total Fee: $2,396.00

Priority of Danish application no. PA 2000 01259 filed on August 25, 2000 is
claimed under 35 U.S.C. 119. A certified copy will be submitted at a later date.

Priority of U.S. provisional application no. 60/231,670 filed on September 9, 2000
is claimed under 35 U.S.C. 119.

Address all future communications to Reza Green, Esq., Novo Nordisk of North
America, Inc., 405 Lexington Avenue, Suite 6400, New York, NY 10174-6401.

Please charge the required fee, estimated to be $2,396 to Novo Nordisk of North
America, Inc., Deposit Account No. 14-1447. A duplicate of this sheet is enclosed.

Date: August 22, 2001

Respectfully submitted,

Valeta A. Gregg, Reg. No.#5, 127(3
Novo Nordisk of North America, Inc.
405 Lexington Avenue, Suite 6400
New York, NY 10174-6401
(212) 867-0123

lllllllllll

23650

PATENT TRADEMARK OFFICE

Attorney Docket No.: 6229.200-US

PATENT

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
EXPRESS MAIL CERTIFICATE

Box Patent Application
Commissioner for Patents
Washington, DC 20231

Re: U.S. Patent Application for

Title: Receptors and Signalling Proteins Capable of Binding Meiotic

Acting Sterols (MAS)

Applicants: Christian Grondahl et al.

Sir:

Express Mail Label No. EL293691641US
Date of Deposit: August 22, 2001

I hereby certify that the following attached paper(s) or fee

1 . Filing Under 37 C.F.R. 1 .53(b) (in duplicate)

2. Patent Application

3. Unexecuted Combined Declaration and Power of Attorney

4. Sequence Listing

are being deposited with the United States Postal Service "Express Mail Post Office to
Addressee" under 37 C.F.R. 1.10 on the date indicated above and is addressed to the
Commissioner for Patents, Washington, DC 20231.

Mailing Address:

Novo Nordisk of North America, Inc.
405 Lexington Avenue, Suite 6400
New York, NY 10017
(212) 867-0123

(Signature of person itrailing paper(s) or fee)

23650

PATENT TRADEMARK OFFICE